Our Research

SRUK fund vital, innovative research into the causes, progression, and treatment of both Scleroderma and Raynaud’s. We have invested over £12 million since the formation of SRUK’s two founding charities. 

We are the only UK charity funding medical research into Raynaud’s and Scleroderma. The research we support results in vital discoveries of new treatments and therapies, and helps to evolve our understanding of the causation and progression of both conditions. Since SRUK’s formation in 2016 we have invested over £2 million in research aligning to the 4 priority areas identified by our community and clinical experts; precision medicine, early detection and diagnosis, quality of life, and causes, as established in our research strategy.

Play video

Get Involved with SRUK's Research! 

Read on to find out more information about upcoming SRUK research initiatives that you can take part in, including community surveys and focus groups. 

SRUK Patient Registry Survey

Follow this link to access our SRUK Patient Registry Survey, to share your views and help shape an exciting upcoming project which aims to support research and improve outcomes for those living with Scleroderma and Raynaud’s: https://www.surveymonkey.co.uk/r/8NH8Z9N 

Watch this webinar 

SRUK's Head of Research, Dr. Emma Blamont, and CEO Sue Farrington discuss what SRUK's research strategy looks like in 2023, and how we got there.

Play video

Read about the projects we're funding and the latest research news 

The Raynaud’s and Scleroderma Association (RSA) and the Scleroderma Society (SS) merged in 2016 to become SRUK, having being founded separately in 1982. Both had a rich history of providing excellent support services to the community and investing in research to improve the knowledge and understanding of these conditions. Between them, they funded over £10 million in research – leading to many breakthroughs which are highlighted in our Impact Report.

SRUK’s research policy is guided by both our Research Strategy, and the Association of Medical Research Charities (AMRC) of which we are a proud member.  

Untitled design (3).jpg

Our statement on the use of animals in research.